Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD

Chronic Respiratory Disease

Volumn 5, Issue 1, 2008, Pages 13-18

  Brophy, C ^a   Kastelik, J A ^a   Gardiner, E ^b   Greenstone, M A ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b West Campus University of Hull ^*  (United Kingdom)

Author keywords

Bronchodilators; COPD; Nebulizers

Indexed keywords

IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; IPRATROPIUM; MALE; METERED DOSE INHALERS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 46149088013     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972307087652     Document Type: Article

References (24)

1. Brandli O. Maintenance and servicing of nebulisers. Eur Respir Rev 1994 ; 4: 102 - 3.
2. Hosker HS, Teale C., Greenstone MA, Muers MF Assessment and provision of home nebulizers for chronic obstructive pulmonary disease (COPD) in the Yorkshire region of the U.K. Resp Med 1995 ; 89: 47 - 52.
3. Melani AS, Sestini P., Aiolfi S. et al. GENebu Project: home nebulizer use and maintenance in Italy. Eur Respir J 2001 ; 18: 758 - 763.
4. O'Driscoll BR Nebulisers for chronic obstructive pulmonary disease. Thorax 1997 ; 52 (Suppl 2). S49 - 52.
5. British Thoracic Society. Current best practice for nebuliser treatment. British Thoracic Society Nebulizer Project Group. Thorax 1997 ; 52 (Suppl 2). S1 - 106.
6. Boe J., Dennis JH, O'Driscoll BR et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001 ; 18: 228 - 42.
7. British Thoracic Society. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004 ; 59 (Suppl 1). 1 - 232.
8. O'Driscoll BR, Kay EA, Taylor RJ, Bernstein A. Home nebulizers: can optimal therapy be predicted by laboratory studies? Resp Med 1990 ; 84: 471 - 77.
9. Teale C., Morrison JF, Muers MF, Pearson SB Response to nebulized ipratropium bromide and terbutaline in acute severe asthma. Resp Med 1992 ; 86: 215 - 18.
10. Morrison JF, Jones PC, Muers MF Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation. Eur Respir J 1992 ; 5: 424 - 29.
11. Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 ; 67: 361 - 70.
12. Guyatt GH, Townsend M., Pugsley SO et al. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis 1987 ; 135: 1069 - 74.
13. Ware JEJ, Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 ; 30: 473 - 83.
14. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991 ; 144: 1202 - 18.
15. Siafakas NM, Vermeire P., Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995 ; 8: 1398 - 420.
16. Nisar M., Walshaw M., Earis JE, Pearson MG, Calverley PM Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 1990 ; 45: 190 - 4.
17. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997 ; 155: 1278 - 82.
18. Jenkins SC, Heaton RW, Fulton TJ, Moxham J. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest 1987 ; 91: 804 - 7.
19. Gervais A., Begin P. Bronchodilatation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulization. Chest 1987 ; 92: 822 - 24.
20. Mestitz H., Copland JM, McDonald CF Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest 1989 ; 96: 1237 - 40.
21. Hansen NC Terbutaline as powder inhalation from Bricanyl Turbuhaler compared to terbutaline as nebulizer solution in severe chronic airways obstruction. Eur Respir J 1989 ; 2: 716 - 20.
22. Morrison JF, Jones PC, Muers MF Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation. Eur Respir J 1992 ; 5: 424 - 29.
23. Goldman JM, Teale C., Muers MF Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy. Resp Med 1992 ; 86: 33 - 38.
24. Williams TJ, Greer L., Jarvis A. The role of body plethysmography data in assessing the bronchodilator response to nebulized salbutamol. Am J Respir Crit Care Med 1996 ; 153: A324 (Abstract).